Alain Moussy

USPTO Granted Patents = 27 (Patent Applications = 21)

CIPO Patents = 7 (Patent Applications = 6)

EPO Patents = 17 (Patent Applications = 25)

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 58(Granted Patents)

Company Filing History:

Centre National De La Recherche Scientifique

Universite Paris Cité

patents

5. 1 out of 316

Assistance Publique-hopitaux De Paris

patents

6. 1 out of 1,743

Institut National De La Sante Et De La Recherche Medicale

patents

7. 1 out of 5

Imagine Institut Des Maladies Genetiques Necker Enfants Malades

patents

where one patent can have more than one assignee

Years Active: 2008-2025

Loading Chart...

27 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12472164 - Masitinib for the treatment of sickle cell disease (2025-11-18),

2. 10570122 - Compounds with anti-tumoral activity (2020-02-25),

3. 10392373 - Oxazole derivatives that inhibit Syk (2019-08-27),

4. 10238649 - Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factors (2019-03-26),

5. 10202370 - Benzimidazole derivatives as selective proteine kinase inhibitors (2019-02-12),

6. 10092564 - Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation (2018-10-09),

7. 10053455 - Diazaspiroalkaneone-substituted oxazole derivatives as spleen tyrosine kinase inhibitors (2018-08-21),

8. 10045978 - Treatment of mastocytosis with masitinib (2018-08-14),

9. 9168245 - Selective protein kinase inhibitors (2015-10-27),

10. 9078894 - Treatment of severe persistant asthma with masitinib (2015-07-14),

11. 8993573 - 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors (2015-03-31),

12. 8962665 - Thiazole and oxazole kinase inhibitors (2015-02-24),

13. 8940894 - Aminothiazole compounds as kinase inhibitors and methods of using the same (2015-01-27),

14. 8906357 - Treatment of multiple sclerosis with masitinib (2014-12-09),

15. 8835435 - 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors (2014-09-16),

Title: Alain Moussy: A Pioneer in Anti-Cancer Innovations

Introduction

Alain Moussy is a prominent inventor based in Paris, France, known for his significant contributions to the field of pharmaceuticals, particularly in developing compounds with anti-tumoral activity. With an impressive portfolio of 26 patents, his work illustrates a commitment to advancing medical science and combating various diseases.

Latest Patents

One of Alain Moussy's latest inventions includes compounds with anti-tumoral activity, which are characterized by a specific general formula involving various chemical groups. These compounds have shown potential in destroying, inhibiting, or preventing the growth and spread of malignant cells, providing therapeutic avenues for treating human and animal diseases.

Another notable patent focuses on oxazole derivatives that inhibit Syk, a type of protein kinase. These substituted oxazole derivatives are designed to selectively modulate and inhibit signal transduction associated with several diseases, including metabolic, autoimmune, and inflammatory disorders. The invention also outlines the process for manufacturing these critical compounds.

Career Highlights

Alain Moussy has made impactful strides in his career, particularly through his work with Ab Science and the Centre National de La Recherche Scientifique (CNRS). His involvement in these prestigious organizations underscores his dedication to research and development in the biomedical field.

Collaborations

Throughout his career, Alain has collaborated with esteemed colleagues such as Abdellah Benjahad and Jean-Pierre Kinet. These partnerships highlight the collaborative nature of research and innovation in the scientific community, particularly in addressing complex health challenges.

Conclusion

In summary, Alain Moussy's work exemplifies the spirit of innovation and dedication required to push the boundaries of medical science. His patents reflect a deep understanding of biochemical mechanisms and a commitment to developing solutions that tackle lif-threatening diseases. As the landscape of pharmaceuticals continues to evolve, inventors like Moussy play a crucial role in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.